Shilna Muttickal Swaminathan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shilna Muttickal Swaminathan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Mohan Varadanayakanahalli Bhojaraja
Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India
5 shared publications - Shankar Prasad Nagaraju
Department of Nephrology, Kasturba medical college, Manipal, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India
5 shared publications - Dharshan Rangaswamy
Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India
4 shared publications - Indu Ramachandra Rao
Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India
4 shared publications - Ravindra Prabhu Attur
Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India
4 shared publications - Srinivas Vinayak Shenoy
Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India
4 shared publications
Latest Publications
- Open Access
- 22 June 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (2) , e26554
Role of C4d and CD68 in kidney biopsy as novel prognostic markers for IgA nephropathy; a single-center study from India
Introduction: IgA nephropathy (IgAN) is a common primary glomerulonephritis worldwide. C4d and CD68 could be useful prognostic markers in this disease. Objectives: This study was conducted to assess the clinical and prognostic implications of C4d and CD68 staining in patients with IgAN. Materials and Methods: This is a retrospective single-center observational study. Baseline characteristics and laboratory details were recorded. Renal biopsy was reported according to the MEST-C classification along with further staining for C4d and CD68 by immunohistochemistry. Primary and secondary outcomes were progression to end-stage renal disease (ESRD) and all-cause mortality during follow-up, respectively. The effect of C4d and CD68 along with other risk factors on outcomes was studied. Results: Sixty patients with primary IgAN were analyzed with a median follow-up of 17 months. Forty were males, with a mean age of 39±16 years, and median estimated glomerular filtration rate (eGFR) of 36.5 mL/min/1.73 m2 with a median urine protein/creatinine ratio of 1.9 g/g, at the time of kidney biopsy. In our patients, macroscopic hematuria (n=2: 3.3%) was rare, while 15 (25%) of patients had nephrotic-range proteinuria. Most biopsies showed sclerosis 43 (71.7%) followed by interstitial fibrosis and tubular atrophy (IFTA) 32(53.3%). Meanwhile, crescents were seen in 20 (33.3%). About 39 (65%) of patients had glomerular C4d positivity and 10 (16.7%) had tubulointerstitial CD68 positivity while, none having glomerular CD68 positivity. Glomerular C4d and tubulointerstitial CD68 positivity had lower eGFR, higher proteinuria at presentation (P<0.05) and faster progression to ESRD (glomerular C4d-odds ratio [OR]: 5.7 [95% CI: 1.4-22.5]); tubulointerstitial CD68 OR: 5.4 [ 95% CI: 1.2-23.95]. Other risk factors predicting progression were eGFR at presentation (OR: 0.9 [95% CI: 0.89-0.99], presence of sclerosis OR: 6.5 [95% CI: 1.32-32.06] and IFTA OR: 21.4 [ 95% CI: 4.3-108]). Conclusion: In our study, IgAN patients presented in the later stages of chronic kidney disease, with the majority being diagnosed at stage 3 of this disease. Macroscopic hematuria was rare and nephrotic syndrome and crescents were common. Glomerular C4d and tubulointerstitial CD68 were associated with lower eGFR and more rapid progression.
- 22 June 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (2) , e26554
Open AccessRole of C4d and CD68 in kidney biopsy as novel prognostic markers for IgA nephropathy; a single-center study from India
Introduction: IgA nephropathy (IgAN) is a common primary glomerulonephritis worldwide. C4d and CD68 could be useful prognostic markers in this disease. Objectives: This study was conducted to assess the clinical and prognostic implications of C4d and CD68 staining in patients with IgAN. Materials and Methods: This is a retrospective single-center observational study. Baseline characteristics and laboratory details were recorded. Renal biopsy was reported according to the MEST-C classification along with further staining for C4d and CD68 by immunohistochemistry. Primary and secondary outcomes were progression to end-stage renal disease (ESRD) and all-cause mortality during follow-up, respectively. The effect of C4d and CD68 along with other risk factors on outcomes was studied. Results: Sixty patients with primary IgAN were analyzed with a median follow-up of 17 months. Forty were males, with a mean age of 39±16 years, and median estimated glomerular filtration rate (eGFR) of 36.5 mL/min/1.73 m2 with a median urine protein/creatinine ratio of 1.9 g/g, at the time of kidney biopsy. In our patients, macroscopic hematuria (n=2: 3.3%) was rare, while 15 (25%) of patients had nephrotic-range proteinuria. Most biopsies showed sclerosis 43 (71.7%) followed by interstitial fibrosis and tubular atrophy (IFTA) 32(53.3%). Meanwhile, crescents were seen in 20 (33.3%). About 39 (65%) of patients had glomerular C4d positivity and 10 (16.7%) had tubulointerstitial CD68 positivity while, none having glomerular CD68 positivity. Glomerular C4d and tubulointerstitial CD68 positivity had lower eGFR, higher proteinuria at presentation (P<0.05) and faster progression to ESRD (glomerular C4d-odds ratio [OR]: 5.7 [95% CI: 1.4-22.5]); tubulointerstitial CD68 OR: 5.4 [ 95% CI: 1.2-23.95]. Other risk factors predicting progression were eGFR at presentation (OR: 0.9 [95% CI: 0.89-0.99], presence of sclerosis OR: 6.5 [95% CI: 1.32-32.06] and IFTA OR: 21.4 [ 95% CI: 4.3-108]). Conclusion: In our study, IgAN patients presented in the later stages of chronic kidney disease, with the majority being diagnosed at stage 3 of this disease. Macroscopic hematuria was rare and nephrotic syndrome and crescents were common. Glomerular C4d and tubulointerstitial CD68 were associated with lower eGFR and more rapid progression.
- Top Cited PapersOpen Access
- 3 April 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2483990
TGF-β: elusive target in diabetic kidney disease
Transforming growth factor-beta (TGF-β), a cytokine with near omnipresence, is an integral part of many vital cellular processes across the human body. The family includes three isoforms: Transforming growth factor-beta 1, 2, and 3. These cytokines play a significant role in the fibrosis cascade. Diabetic kidney disease (DKD), a major complication of diabetes, is increasing in prevalence daily, and the classical diagnosis of diabetes is based on the presence of albuminuria. The occurrence of nonalbuminuric DKD has provided new insight into the pathogenesis of this disease. The emphasis on multifactorial pathways involved in developing DKD has highlighted some markers associated with tissue fibrosis. In diabetic nephropathy, TGF-β is significantly involved in its pathology. Its presence in serum and urine means that it could be a diagnostic tool while its regulation provides potential therapeutic targets. Completely blocking TGF-β signaling could reach untargeted regions and cause unanticipated effects. This paper reviews the basic details of TGF-β as a cytokine, its role in DKD, and updates on research carried out to validate its candidacy.
- 3 April 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2483990
Top Cited PapersOpen AccessTGF-β: elusive target in diabetic kidney disease
Transforming growth factor-beta (TGF-β), a cytokine with near omnipresence, is an integral part of many vital cellular processes across the human body. The family includes three isoforms: Transforming growth factor-beta 1, 2, and 3. These cytokines play a significant role in the fibrosis cascade. Diabetic kidney disease (DKD), a major complication of diabetes, is increasing in prevalence daily, and the classical diagnosis of diabetes is based on the presence of albuminuria. The occurrence of nonalbuminuric DKD has provided new insight into the pathogenesis of this disease. The emphasis on multifactorial pathways involved in developing DKD has highlighted some markers associated with tissue fibrosis. In diabetic nephropathy, TGF-β is significantly involved in its pathology. Its presence in serum and urine means that it could be a diagnostic tool while its regulation provides potential therapeutic targets. Completely blocking TGF-β signaling could reach untargeted regions and cause unanticipated effects. This paper reviews the basic details of TGF-β as a cytokine, its role in DKD, and updates on research carried out to validate its candidacy.
- Open Access
- 14 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e12724
The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review
Lupus nephritis (LN) is a major organ condition in systemic lupus erythematosus (SLE) leading to end-stage kidney disease if not managed effectively. Two main therapeutic approaches that are successful in the management of LN include immunosuppression and non-immunosuppressive drugs, renin-angiotensin-aldosterone system inhibitors, and hydroxychloroquine (HCQ), which are supported by numerous clinical trials. Recent clinical trials with sodium-glucose cotransporter-2 inhibitors (SGLT2i) have consistently shown substantial evidence of reno-protection for those with IgA nephropathy and focal segmental glomerulosclerosis. However, emerging evidence shows the protective role of SGLT2i in renal outcomes for the management of LN. This review explores the underlying mechanisms by which SGLT2i contributes to nephroprotection, with promising evidence from both animal and human studies, and guideline recommendations regarding its utilization in LN.
- 14 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e12724
Open AccessThe efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review
Lupus nephritis (LN) is a major organ condition in systemic lupus erythematosus (SLE) leading to end-stage kidney disease if not managed effectively. Two main therapeutic approaches that are successful in the management of LN include immunosuppression and non-immunosuppressive drugs, renin-angiotensin-aldosterone system inhibitors, and hydroxychloroquine (HCQ), which are supported by numerous clinical trials. Recent clinical trials with sodium-glucose cotransporter-2 inhibitors (SGLT2i) have consistently shown substantial evidence of reno-protection for those with IgA nephropathy and focal segmental glomerulosclerosis. However, emerging evidence shows the protective role of SGLT2i in renal outcomes for the management of LN. This review explores the underlying mechanisms by which SGLT2i contributes to nephroprotection, with promising evidence from both animal and human studies, and guideline recommendations regarding its utilization in LN.
- Open Access
- 23 October 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (4) , e38335
Outcomes of arteriovenous fistula and role of duplex ultrasound for its assessment in pre-dialysis patients; a single center longitudinal study
Introduction: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis; however, it has a primary failure rate of 20%–60%. Analyzing the factors associated with AVF failure is crucial for planning appropriate management strategies. Objectives: We aimed to identify the AVF outcomes and associated factors along with the role of duplex ultrasound (DUS) in preoperative and postoperative AVF assessment at a tertiary care hospital. Patients and Methods: This prospective observational study was conducted on pre-dialysis patients who underwent AVF creation between January 2020 and December 2021.AVF outcomes and associated clinical and vascular factors were analyzed using pre- and post-operative DUS. Results: Of 171 patients, males were predominant (83.6%), and diabetic nephropathy (42.7%) was the predominant cause of chronic kidney disease (CKD). AVF outcomes showed, 109 (63.7%) had unassisted mature AVF and 29 (16.9%) had AVF failure wherein early dialysis suitability failure was predominant (17; 9.94%). Among clinical factors, only a history of smoking correlated with AVF failure (P=0.04). On pre-and post-operative DUS assessment, the absence of distensibility and immediate post-operative vein diameter strongly correlated with AVF failure (P<0.001). A unit increase (1 mm) in outflow vein diameter immediately after surgery emerged as an independent predictor of AVF outcome in both univariate (OR 0.98, 95% CI: 0.35-3.99; P<0.001) and multivariate analysis (OR: 0.313, 95% CI: 0.148-0.663; P<0.001). Conclusion: Most patients in our setting had unassisted AVF fistula. We additionally found that smoking correlated with AVF failure. Predominant factors determining AVF success were cephalic vein diameter, distensibility, and increase in draining vein diameter and flow volume at six weeks. This study highlights using DUS in pre- and post-operative periods, along with conventional examination to improve AVF outcomes.
- 23 October 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (4) , e38335
Open AccessOutcomes of arteriovenous fistula and role of duplex ultrasound for its assessment in pre-dialysis patients; a single center longitudinal study
Introduction: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis; however, it has a primary failure rate of 20%–60%. Analyzing the factors associated with AVF failure is crucial for planning appropriate management strategies. Objectives: We aimed to identify the AVF outcomes and associated factors along with the role of duplex ultrasound (DUS) in preoperative and postoperative AVF assessment at a tertiary care hospital. Patients and Methods: This prospective observational study was conducted on pre-dialysis patients who underwent AVF creation between January 2020 and December 2021.AVF outcomes and associated clinical and vascular factors were analyzed using pre- and post-operative DUS. Results: Of 171 patients, males were predominant (83.6%), and diabetic nephropathy (42.7%) was the predominant cause of chronic kidney disease (CKD). AVF outcomes showed, 109 (63.7%) had unassisted mature AVF and 29 (16.9%) had AVF failure wherein early dialysis suitability failure was predominant (17; 9.94%). Among clinical factors, only a history of smoking correlated with AVF failure (P=0.04). On pre-and post-operative DUS assessment, the absence of distensibility and immediate post-operative vein diameter strongly correlated with AVF failure (P<0.001). A unit increase (1 mm) in outflow vein diameter immediately after surgery emerged as an independent predictor of AVF outcome in both univariate (OR 0.98, 95% CI: 0.35-3.99; P<0.001) and multivariate analysis (OR: 0.313, 95% CI: 0.148-0.663; P<0.001). Conclusion: Most patients in our setting had unassisted AVF fistula. We additionally found that smoking correlated with AVF failure. Predominant factors determining AVF success were cephalic vein diameter, distensibility, and increase in draining vein diameter and flow volume at six weeks. This study highlights using DUS in pre- and post-operative periods, along with conventional examination to improve AVF outcomes.
- Open Access
- 10 August 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 13 (4) , e21516
Study of clinical and histopathological factors predicting rapid progression in biopsy-proven type 2 diabetic kidney disease
Introduction: Rapid progression of diabetic kidney disease (DKD) is a significant concern, particularly in developing countries. It remains uncertain whether histopathological parameters, in addition to clinical factors, can predict DKD progression. Objectives: To evaluate renal histopathological and clinical parameters in predicting rapid progression to end-stage kidney disease (ESKD) in type 2 diabetes mellitus (Type 2 DM) patients with biopsy-proven DKD. Patients and Methods: This was an observational retrospective study that included 49 biopsy-proven DKD from January 2018 to December 2022. Those with less than six months of follow-up and CKD stage 5 were excluded. The outcomes studied were rapid progression and progression to ESKD. Patients were categorized into rapid progressors and non-progressors based on the estimated glomerular filtration (eGFR) decline of > or <10 mL/min/1.73 m2 /year, respectively. The association of histopathological factors and clinical parameters with rapid progression and independent risk factors for progression to ESKD were analysed using SPSS 22. Results: In a median follow-up of 1.6 years, 57% were rapid progressors, and 42.9% were non-progressors, with a median eGFR decline of 21 mL/min/1.73 m2 /year and 5 mL/min/1.73 m2 /year, respectively. Among histopathological factors, global glomerular sclerosis (class 4) predicted rapid progression (P= 0.03), since among clinical factors, hypertension (89.3%) elevated hemoglobin A1c (HbA1c) (9.6%), and massive proteinuria (75.1%) were significant parameters associated with rapid progression (P<0.05). In Cox regression analysis, the progression to ESKD was independently associated with global glomerular sclerosis (HR 1.1, CI 1.0-1.4, P=0.04) and massive proteinuria (HR 1.6, CI 1.0-2.1, P=0.01) Conclusion: In our cohort, hypertension, high HbA1c, severe proteinuria, and global glomerular sclerosis (Class 4) were associated with rapid progression. Severe proteinuria and global glomerular sclerosis were independent risk factors for progression to ESKD. This highlights the need for large prospective studies in identifying the factors predicting rapid progressors in DKD; therefore, timely intervention can be considered.
- 10 August 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 13 (4) , e21516
Open AccessStudy of clinical and histopathological factors predicting rapid progression in biopsy-proven type 2 diabetic kidney disease
Introduction: Rapid progression of diabetic kidney disease (DKD) is a significant concern, particularly in developing countries. It remains uncertain whether histopathological parameters, in addition to clinical factors, can predict DKD progression. Objectives: To evaluate renal histopathological and clinical parameters in predicting rapid progression to end-stage kidney disease (ESKD) in type 2 diabetes mellitus (Type 2 DM) patients with biopsy-proven DKD. Patients and Methods: This was an observational retrospective study that included 49 biopsy-proven DKD from January 2018 to December 2022. Those with less than six months of follow-up and CKD stage 5 were excluded. The outcomes studied were rapid progression and progression to ESKD. Patients were categorized into rapid progressors and non-progressors based on the estimated glomerular filtration (eGFR) decline of > or <10 mL/min/1.73 m2 /year, respectively. The association of histopathological factors and clinical parameters with rapid progression and independent risk factors for progression to ESKD were analysed using SPSS 22. Results: In a median follow-up of 1.6 years, 57% were rapid progressors, and 42.9% were non-progressors, with a median eGFR decline of 21 mL/min/1.73 m2 /year and 5 mL/min/1.73 m2 /year, respectively. Among histopathological factors, global glomerular sclerosis (class 4) predicted rapid progression (P= 0.03), since among clinical factors, hypertension (89.3%) elevated hemoglobin A1c (HbA1c) (9.6%), and massive proteinuria (75.1%) were significant parameters associated with rapid progression (P<0.05). In Cox regression analysis, the progression to ESKD was independently associated with global glomerular sclerosis (HR 1.1, CI 1.0-1.4, P=0.04) and massive proteinuria (HR 1.6, CI 1.0-2.1, P=0.01) Conclusion: In our cohort, hypertension, high HbA1c, severe proteinuria, and global glomerular sclerosis (Class 4) were associated with rapid progression. Severe proteinuria and global glomerular sclerosis were independent risk factors for progression to ESKD. This highlights the need for large prospective studies in identifying the factors predicting rapid progressors in DKD; therefore, timely intervention can be considered.